EAGLE CRAIG 4

4 · Guardant Health, Inc. · Filed Mar 17, 2026

AI-generated summary of this filing

Updated Mar 17, 2026

Guardant Health (GH) CMO Craig Eagle Receives RSUs; Shares Withheld for Taxes

What Happened

Craig Eagle, Chief Medical Officer of Guardant Health, had restricted stock units (RSUs) vest on March 15, 2026. A total of 15,114 shares were converted/exercised from derivative awards (13,712 + 1,402) at $0.00 per share (reflecting vesting, not a cash purchase).
To satisfy tax withholding, the company retained (disposed) 7,661 of those shares at $85.49 per share, resulting in proceeds of $654,939. The net shares delivered to Eagle were 7,453 (15,114 vested minus 7,661 withheld).

Key Details

Transaction date: March 15, 2026 (Form 4 filed March 17, 2026).
Conversion/vesting: 13,712 and 1,402 shares (total 15,114) reported as exercised/converted (transaction code M) at $0.00.
Tax withholding: 7,661 shares withheld/disposed (transaction code F) at $85.49; total reported proceeds $654,939.
Net shares issued to insider: 7,453 shares.
Shares owned after transaction: Not disclosed in the provided filing details.
Footnotes of note:
- F1: Company retained shares only to meet the award-holder’s tax withholding obligation; not in excess of the tax liability.
- F2: The 1,402-share component is from a performance-based RSU grant (June 7, 2023) whose second tranche vested on March 15, 2026.
- F4: The 13,712-share component relates to a time-based RSU grant (June 9, 2023) with scheduled vesting over three years.
Filing timeliness: Form filed two days after the transaction date; no late filing flag indicated in the provided data.

Context

These entries reflect RSU vesting and company share-withholding for taxes (a common, routine administrative step), not an open-market sale or purchase by the insider. Acquisitions at $0.00 indicate receipt of vested awards rather than a cash purchase. Withholding to cover taxes should not be interpreted as a directional investment signal.

Form 4

Period: 2026-03-15

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2026-03-15+13,712→ 72,639 total
Exercise/Conversion
Common Stock
2026-03-15+1,402→ 74,041 total
Tax Payment
Common Stock
[F1]
2026-03-15$85.49/sh−7,661$654,939→ 66,380 total
Exercise/Conversion
Performance-Based Restricted Stock Units
[F2][F3]
2026-03-15−13,712→ 0 total
Exercise: $0.00→ Common Stock (13,712 underlying)
Exercise/Conversion
Restricted Stock Units
[F4][F3]
2026-03-15−1,402→ 1,402 total
Exercise: $0.00→ Common Stock (1,402 underlying)

Footnotes (4)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026.
[F3]Not applicable for Restricted Stock Units.
[F4]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Signature

/s/ John G. Saia, as attorney-in-fact for Craig Eagle|2026-03-17

1 file